Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38325
CAS Number:
10405-02-4
Chlorure de trospium
Purity:
≥ 98 % (HPLC)
Documents
$197.60 /200 mg
Taille
Request Bulk Quote
Informations sur le produit

Trospium chloride is a quaternary ammonium compound primarily utilized in the treatment of overactive bladder and urinary incontinence. This medication works by inhibiting the action of acetylcholine on muscarinic receptors in the bladder, leading to reduced bladder contractions and improved urinary control. Its unique spirocyclic structure enhances its selectivity and efficacy, making it a preferred choice in clinical settings. Trospium chloride is particularly advantageous due to its minimal central nervous system penetration, which reduces the risk of side effects commonly associated with anticholinergic medications, such as sedation and cognitive impairment.

In addition to its therapeutic applications, Trospium chloride is also of interest in pharmaceutical research for developing new formulations and delivery methods. Its stability and solubility properties make it suitable for various dosage forms, including tablets and extended-release capsules. Researchers and healthcare professionals appreciate Trospium chloride for its effectiveness and safety profile, making it a valuable compound in both clinical and research environments.

Numéro CAS 
10405-02-4
Formule moléculaire
C 25 H 30 ClNO 3
Poids moléculaire 
427.97
Point de fusion 
261 - 263 °C (déc.)
Informations générales
Numéro CAS 
10405-02-4
Formule moléculaire
C 25 H 30 ClNO 3
Poids moléculaire 
427.97
Point de fusion 
261 - 263 °C (déc.)
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Trospium chloride is widely utilized in research focused on

  • Urology: This compound is primarily used to treat overactive bladder symptoms, providing relief for patients by reducing urinary urgency and frequency.
  • Pharmaceutical Development: Trospium chloride serves as a model compound in drug formulation studies, helping researchers understand the pharmacokinetics and pharmacodynamics of anticholinergic medications.
  • Clinical Trials: It is often a subject in clinical trials aimed at evaluating new therapies for bladder control issues, allowing researchers to compare efficacy and safety profiles against other treatments.
  • Research on Anticholinergic Effects: This chemical is used in studies investigating the broader effects of anticholinergic agents on cognitive function, particularly in elderly populations.
  • Combination Therapies: Trospium chloride is explored in combination with other medications to enhance therapeutic outcomes in managing urinary disorders, offering a more comprehensive approach to treatment.

Citations